William B White

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

Journal of cardiovascular pharmacology and therapeutics

Journal of clinical pharmacology

Hypertension (Dallas, Tex. : 1979)

The New England journal of medicine

University of Connecticut School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Connecticut School of Medicine Jul 01 1978

United States

Professor :: Cardiology

Publications

William B White
Henry R. Black, MD (1942-2024). Hypertension (Dallas, Tex. : 1979) 81 (9) (2024)
William B White
Henry R. Black, MD (1942-2024). Hypertension (Dallas, Tex. : 1979) 81 (9) (2024)
Rajiv Agarwal, Patrick Rossignol, Martha R Mayo, Ansgar Conrad, Susan Arthur, Bryan Williams, William B White
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Clinical journal of the American Society of Nephrology : CJASN 16 (9) (2021)
William B White, James S Bernstein, Roger Rittmaster, Om Dhingra
Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men. Journal of clinical hypertension (Greenwich, Conn.) 23 (7) (2021)
William B White, Adrian Dobs, Culley Carson, Anthony DelConte, Mohit Khera, Martin Miner, Muhammad Shahid, Kilyoung Kim, Nachiappan Chidambaram
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. Journal of cardiovascular pharmacology and therapeutics 26 (6) (2021)
William B White, Robert A Kloner, Dominick J Angiolillo, Michael H Davidson
Cardiorenal Safety of OTC Analgesics. Journal of cardiovascular pharmacology and therapeutics 23 (2) (2019)
William B White, Peter Kowey, Ulysses Diva, Mark Sostek, Raj Tummala
Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation. Journal of cardiovascular pharmacology and therapeutics 23 (4) (2018)
William B White, Kenneth G Saag, Michael A Becker, Jeffrey S Borer, Philip B Gorelick, Andrew Whelton, Barbara Hunt, Majin Castillo, Lhanoo Gunawardhana, null null
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. The New England journal of medicine 378 (13) (2018)
Regan Fong, Charles H Ballow, Himanshu Naik, Deb Steiner, Joanne Palmer, William B White
Effects of a State- and Use-Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study. Journal of clinical pharmacology 59 (1) (2018)
William B White, Christopher Chapple, Christian Gratzke, Sender Herschorn, Dudley Robinson, Jeffrey Frankel, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Robert van Maanen, Michael A Weber
Cardiovascular Safety of the β3 -Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. Journal of clinical pharmacology 58 (8) (2018)
You-Cheol Hwang, David A Morrow, Christopher P Cannon, Yuyin Liu, Richard Bergenstal, Simon R Heller, Cyrus Mehta, William Cushman, George L Bakris, Faiez Zannad, William B White
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial. Diabetes, obesity & metabolism 20 (3) (2017)

William B White.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

William B White